...
首页> 外文期刊>European Radiology >Choledocholithiasis: repetitive thick-slab single-shot projection magnetic resonance cholangiopancreaticography versus endoscopic ultrasonography
【24h】

Choledocholithiasis: repetitive thick-slab single-shot projection magnetic resonance cholangiopancreaticography versus endoscopic ultrasonography

机译:胆总管结石:重复厚板单发投射磁共振胆胰管成像与内镜超声检查

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This prospective study compares repetitive thick-slab single-shot projection magnetic resonance cholangiopancreatography (MRCP) with endoscopic ultrasonography (EUS) for the detection of choledocholithiasis. Fifty-seven consecutive patients (36 women, mean age 61) referred for suspected choledocholithiasis underwent MRCP, followed by EUS. Each procedure was performed by different operators blinded to the results of the other investigation. MR technique included a turbo spin-echo T2-weighted axial sequence with selective fat saturation (SPIR/TSE, TE=70 ms, TR=1,600 ms), followed by coronal dynamic MRCP. The same thick-slab slice was sequentially acquired 12 times as breath-hold single-shot projection imaging (SSh, TE=900 ms, TE=8,000 ms) centred on the common bile duct (CBD). Two experienced radiologists independently and blindly evaluated MR images for the detection of CBD stones. Their inter-observer agreement kappa was determined. Secondly, the two observers read MR images in consensus again. CBD stones were demonstrated in 18 out of 57 patients (31.6 %) and confirmed by endoscopic retrograde cholangiography (ERCP, n=17) or intraoperative cholangiography (n=1). Clinical follow-up served as the “gold standard” in patients with negative results without following invasive procedure (n=28). Sensitivity, specificity, accuracy, positive and negative predictive value for MRCP resulting from consensus reading were 94.9%, 94.4%, 94.7%, 97.4% and 89.5%, respectively. Corresponding values of EUS were 97.4%, 94.4%, 96.5%, 97.4% and 94.4%. Inter-observer agreement kappa was 0.81. Repetitive thick-slab single-shot projection MRCP is an accurate non-invasive imaging modality for suspected choledocholithiasis and should be increasingly used to select those patients who require a subsequent therapeutic procedure, namely ERCP.
机译:这项前瞻性研究比较了重复厚板单次投射磁共振胰胆管造影(MRCP)和内镜超声检查(EUS)来检测胆总管结石症。接受MRCP治疗的连续57例患者(36名女性,平均年龄61岁)因疑似胆总管结石而接受了MRCP治疗,其次是EUS。每个程序都是由对其他调查结果不了解的不同操作员执行的。 MR技术包括具有选择性脂肪饱和度的涡轮自旋回波T2加权轴向序列(SPIR / TSE,TE = 70毫秒,TR = 1,600毫秒),其次是冠状动态MRCP。顺序获取相同的厚厚切片切片,作为以胆总管(CBD)为中心的屏气单次投射成像(SSh,TE = 900 ms,TE = 8,000 ms)。两名经验丰富的放射科医生独立并盲目地评估了MR图像以检测CBD结石。他们的观察员之间的共识app已确定。其次,两个观察者再次一致地读取MR图像。 57名患者中有18名(31.6%)表现出CBD结石,并通过内镜逆行胆管造影(ERCP,n = 17)或术中胆管造影(n = 1)证实。在没有遵循侵入性程序的情况下,阴性结果患者的临床随访成为“金标准”(n = 28)。共识性阅读对MRCP的敏感性,特异性,准确性,阳性和阴性预测值分别为94.9%,94.4%,94.7%,97.4%和89.5%。 EUS的相应值分别为97.4%,94.4%,96.5%,97.4%和94.4%。观察者间协议的kappa为0.81。重复厚板单发投射MRCP是可疑胆总管结石症的准确无创成像方式,应越来越多地用于选择需要后续治疗程序即ERCP的患者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号